Table of contents
Volume 91, Issue 2
Published online 13 July 2004 (195-412)
Clinical |
Molecular and Cellular Pathology |
Genetics and Genomics |
Experimental Therapeutics
Minireviews
Status of selenium in prostate cancer prevention FREE
G F Combs Jr
Br J Cancer 91: 195-199; advance online publication, June 22, 2004; doi:10.1038/sj.bjc.6601974
Detection of circulating Tg-mRNA in the follow-up of papillary and follicular thyroid cancer: how useful is it? FREE
F A Verburg, C J M Lips, E G W M Lentjes and J M H de Klerk
Br J Cancer 91: 200-204; advance online publication, June 22, 2004; doi:10.1038/sj.bjc.6601991
Clinical
The relationship between hypoalbuminaemia, tumour volume and the systemic inflammatory response in patients with colorectal liver metastases FREE
R Al-Shaiba, D C McMillan, W J Angerson, E Leen, C S McArdle and P Horgan
Br J Cancer 91: 205-207; advance online publication, June 22, 2004; doi:10.1038/sj.bjc.6601886
Analysis of epidermal growth factor receptor expression as a predictive factor for response to gefitinib ('Iressa', ZD1839) in non-small-cell lung cancer FREE
H S Parra, R Cavina, F Latteri, P A Zucali, E Campagnoli, E Morenghi, G C Grimaldi, M Roncalli and A Santoro
Br J Cancer 91: 208-212; advance online publication, June 8, 2004; doi:10.1038/sj.bjc.6601923
Phase I trial of the novel taxane BMS-184476 administered in combination with carboplatin every 21 days FREE
J H Bilenker, J P Stevenson, M L Gallagher, D Vaughn, M B Cohen and P J O'Dwyer
Br J Cancer 91: 213-218; advance online publication, June 22, 2004; doi:10.1038/sj.bjc.6601885
Vascular endothelial growth factor (VEGF) in leptomeningeal metastasis: diagnostic and prognostic value FREE
U Herrlinger, H Wiendl, M Renninger, H Förschler, J Dichgans and M Weller
Br J Cancer 91: 219-224; advance online publication, June 22, 2004; doi:10.1038/sj.bjc.6601953
Establishing long-term survival and cure in young patients with Ewing's sarcoma FREE
C L Weston, C Douglas, A W Craft, I J Lewis and D Machin on behalf of UKCCSG
Br J Cancer 91: 225-232; advance online publication, June 22, 2004; doi:10.1038/sj.bjc.6601955
Interaction of dense breast patterns with other breast cancer risk factors in a case–control study FREE
S W Duffy, R W Jakes, F C Ng and F Gao
Br J Cancer 91: 233-236; advance online publication, June 8, 2004; doi:10.1038/sj.bjc.6601911
Primary breast sarcoma: clinicopathologic series from the Mayo Clinic and review of the literature FREE
C Adem, C Reynolds, J N Ingle and A G Nascimento
Br J Cancer 91: 237-241; advance online publication, June 8, 2004; doi:10.1038/sj.bjc.6601920
Trends in the usage of adjuvant systemic therapy for breast cancer in the Netherlands and its effect on mortality FREE
M M Vervoort, G Draisma, J Fracheboud, L V van de Poll-Franse and H J de Koning
Br J Cancer 91: 242-247; advance online publication, June 22, 2004; doi:10.1038/sj.bjc.6601969
A new quality assurance package for hospital palliative care teams: the Trent Hospice Audit Group model FREE
J Hunt, V L Keeley, M Cobb and S H Ahmedzai
Br J Cancer 91: 248-253; advance online publication, June 22, 2004; doi:10.1038/sj.bjc.6601945
Beliefs and practices of patients with advanced cancer: implications for communication FREE
G F Beadle, P M Yates, J M Najman, A Clavarino, D Thomson, G Williams, L Kenny, S Roberts, B Mason and D Schlect
Br J Cancer 91: 254-257; advance online publication, June 22, 2004; doi:10.1038/sj.bjc.6601950
Molecular and Cellular Pathology
Loss of HOP tumour suppressor expression in head and neck squamous cell carcinoma FREE
F Lemaire, R Millon, D Muller, Y Rabouel, L Bracco, J Abecassis and B Wasylyk
Br J Cancer 91: 258-261; advance online publication, June 22, 2004; doi:10.1038/sj.bjc.6601952
DNA replication licensing and cell cycle kinetics of oligodendroglial tumours FREE
S B Wharton, S Hibberd, K L Eward, D Crimmins, D A Jellinek, D Levy, K Stoeber and G H Williams
Br J Cancer 91: 262-269; advance online publication, June 15, 2004; doi:10.1038/sj.bjc.6601949
Reduced expression of small GTPases and hypermethylation of the folate binding protein gene in cisplatin-resistant cells FREE
D-W Shen, A Su, X-J Liang, A Pai-Panandiker and M M Gottesman
Br J Cancer 91: 270-276; advance online publication, June 15, 2004; doi:10.1038/sj.bjc.6601956
Predicting aggressive outcome in T1N0M0 breast cancer FREE
P Kronqvist, T Kuopio, M Nykänen, H Helenius, J Anttinen, P Klemi and South-Western Finland Breast Cancer Group
Br J Cancer 91: 277-281; advance online publication, June 15, 2004; doi:10.1038/sj.bjc.6601948
Clinical significance of elongation factor-1 delta mRNA expression in oesophageal carcinoma FREE
K Ogawa, T Utsunomiya, K Mimori, Y Tanaka, F Tanaka, H Inoue, S Murayama and M Mori
Br J Cancer 91: 282-286; advance online publication, June 15, 2004; doi:10.1038/sj.bjc.6601941
Identification of parathyroid hormone-related protein-derived peptides immunogenic in human histocompatibility leukocyte antigen-A24+ prostate cancer patients FREE
A Yao, M Harada, S Matsueda, Y Ishihara, H Shomura, M Noguchi, K Matsuoka, I Hara, S Kamidono and K Itoh
Br J Cancer 91: 287-296; advance online publication, June 15, 2004; doi:10.1038/sj.bjc.6601960
Cytotoxic effect of a new 1,3,4-thiadiazolium mesoionic compound (MI-D) on cell lines of human melanoma FREE
A Senff-Ribeiro, A Echevarria, E F Silva, C R C Franco, S S Veiga and M B M Oliveira
Br J Cancer 91: 297-304; advance online publication, June 15, 2004; doi:10.1038/sj.bjc.6601946
Prolactin acts as a potent survival factor for human breast cancer cell lines FREE
C M Perks, A J Keith, K L Goodhew, P B Savage, Z E Winters and J M P Holly
Br J Cancer 91: 305-311; advance online publication, June 22, 2004; doi:10.1038/sj.bjc.6601947
Pathological features and genetic alterations in colorectal carcinomas with characteristics of nonpolypoid growth FREE
K Kaneko, T Kurahashi, R Makino, K Konishi, H Ito, A Katagiri, Y Kumekawa, Y Hirayama, K Yoneyama, M Kushima, M Kusano, H Tajiri, B J Rembacken, K Mitamura and M Imawari
Br J Cancer 91: 312-318; advance online publication, June 22, 2004; doi:10.1038/sj.bjc.6601965
Protein expression patterns in primary carcinoma of the vagina FREE
K Hellman, A A Alaiya, K Schedvins, W Steinberg, A-C Hellström and G Auer
Br J Cancer 91: 319-326; advance online publication, June 15, 2004; doi:10.1038/sj.bjc.6601944
Genetics and Genomics
Telomere shortening and mitotic dysfunction generate cytogenetic heterogeneity in a subgroup of renal cell carcinomas FREE
D Gisselsson, L Gorunova, M Höglund, N Mandahl and P Elfving
Br J Cancer 91: 327-332; advance online publication, May 25, 2004; doi:10.1038/sj.bjc.6601803
Resveratrol inhibits benzo[a]pyrene–DNA adduct formation in human bronchial epithelial cells FREE
G Berge, S Øvrebø, I V Botnen, A Hewer, D H Phillips, A Haugen and S Mollerup
Br J Cancer 91: 333-338; advance online publication, May 25, 2004; doi:10.1038/sj.bjc.6601898
Polymorphisms in prostaglandin synthase 2/cyclooxygenase 2 (PTGS2/COX2) and risk of colorectal cancer FREE
D G Cox, C Pontes, E Guino, M Navarro, A Osorio, F Canzian and V Moreno for the Bellvitge Colorectal Cancer Study Group
Br J Cancer 91: 339-343; advance online publication, June 1, 2004; doi:10.1038/sj.bjc.6601906
A multivariate analysis of genomic polymorphisms: prediction of clinical outcome to 5-FU/oxaliplatin combination chemotherapy in refractory colorectal cancer FREE
J Stoehlmacher, D J Park, W Zhang, D Yang, S Groshen, S Zahedy and H-J Lenz
Br J Cancer 91: 344-354; advance online publication, June 22, 2004; doi:10.1038/sj.bjc.6601975
The COSMIC (Catalogue of Somatic Mutations in Cancer) database and website FREE
S Bamford, E Dawson, S Forbes, J Clements, R Pettett, A Dogan, A Flanagan, J Teague, P A Futreal, M R Stratton and R Wooster
Br J Cancer 91: 355-358; advance online publication, June 8, 2004; doi:10.1038/sj.bjc.6601894
Experimental Therapeutics
Antimetastatic activity of a cyclooxygenase-2 inhibitor FREE
G Roche-Nagle, E M Connolly, M Eng, D J Bouchier-Hayes and J H Harmey
Br J Cancer 91: 359-365; advance online publication, June 22, 2004; doi:10.1038/sj.bjc.6601967
Targeted radiosensitisation by pegylated liposome-encapsulated 3', 5'-O-dipalmitoyl 5-iodo-2'-deoxyuridine in a head and neck cancer xenograft model FREE
K J Harrington, K N Syrigos, P S Uster, A Zetter, C R Lewanski, W J Gullick, R G Vile and J S W Stewart
Br J Cancer 91: 366-373; advance online publication, June 15, 2004; doi:10.1038/sj.bjc.6601958
Assessment of vascular reactivity in rat brain glioma by measuring regional blood volume during graded hypoxic hypoxia FREE
C Julien, J-F Payen, I Troprès, R Farion, E Grillon, O Montigon and C Rémy
Br J Cancer 91: 374-380; advance online publication, June 8, 2004; doi:10.1038/sj.bjc.6601908
Evidence for colorectal cancer cell specificity of aspirin effects on NF
B signalling and apoptosis FREE
F V N Din, M G Dunlop and L A Stark
Br J Cancer 91: 381-388; advance online publication, June 8, 2004; doi:10.1038/sj.bjc.6601913
Alterations in neuroblastoma ganglioside synthesis by induction of GD1b synthase by retinoic acid FREE
S Hettmer, R McCarter, S Ladisch and K Kaucic
Br J Cancer 91: 389-397; advance online publication, June 8, 2004; doi:10.1038/sj.bjc.6601914
MAGE-A8 overexpression in transitional cell carcinoma of the bladder: identification of two tumour-associated antigen peptides FREE
E Bar-Haim, A Paz, A Machlenkin, D Hazzan, B Tirosh, L Carmon, B Brenner, E Vadai, O Mor, A Stein, F A Lemonnier, E Tzehoval and L Eisenbach
Br J Cancer 91: 398-407; advance online publication, June 22, 2004; doi:10.1038/sj.bjc.6601968
Effect of eicosapentaenoic acid, protein and amino acids on protein synthesis and degradation in skeletal muscle of cachectic mice FREE
H J Smith, N A Greenberg and M J Tisdale
Br J Cancer 91: 408-412; advance online publication, June 22, 2004; doi:10.1038/sj.bjc.6601981
The published online date indicates the date that the issue is published online and is the first official publication date of the issue. Each print issue of BJC is published one week after it has been published online.
